Advances in the Treatment of Non–small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab

Konstantinos Leventakos, Aaron S. Mansfield

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Advances in the Treatment of Non–small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences